CC chemokine ligand 18 correlates with malignant progression of prostate cancer

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Chen, Guo ^a   Liang, Yu Xiang ^a   Zhu, Jian Guo ^b   Fu, Xin ^a   Chen, Yan Fei ^a   Mo, Ru Jun ^a   Zhou, Liang ^a   Fu, Hao ^c   Bi, Xue Cheng ^d   He, Hui Chan ^a   Yang, Sheng Bang ^a   Wu, Yong Ding ^a   Jiang, Fu Neng ^a   Zhong, Wei De ^a,e  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b GUIZHOU PROVINCIAL PEOPLE'S HOSPITAL   (China)

^c UNIVERSITY OF SOUTH CHINA   (China)

^d GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^e SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; CHEMOKINE; CXCL18 CHEMOKINE; KI 67 ANTIGEN; MESSENGER RNA; UNCLASSIFIED DRUG; BETA CHEMOKINE; CCL18 PROTEIN, HUMAN;

AGED; ALLOGRAFT; APOPTOSIS; ARTICLE; CANCER GROWTH; CELL INVASION; CELL MIGRATION; CELL STIMULATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE EXPRESSION; GLEASON SCORE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VASCULARIZATION; TUMOR XENOGRAFT; UPREGULATION; ANIMAL; C57BL MOUSE; CELL MOTION; CELL PROLIFERATION; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PROSTATE TUMOR; PROTEIN TRANSPORT; TUMOR CELL LINE; TUMOR INVASION; VASCULARIZATION;

AGED; ALLOGRAFTS; ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CHEMOKINES, CC; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICE, INBRED C57BL; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; PROSTATIC NEOPLASMS; PROTEIN TRANSPORT; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84907494124     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/230183     Document Type: Article

References (23)

1. R. Siegel, D. Naishadham, and A. Jemal, "Cancer statistics, 2013," CA: A Cancer Journal for Clinicians, vol. 63, no. 1, pp. 11-30, 2013.
2. J. Molitierno, A. Evans, J. L. Mohler, E. Wallen, D. Moore, and R. S. Pruthi, "Characterization of biochemical recurrence after radical prostatectomy," Urologia Internationalis, vol. 77, no. 2, pp. 130-134, 2006.
3. L. Klotz, "Hormone therapy for patients with prostate carcinoma," Cancer, vol. 88, no. 12, supplement, pp. 3009-3014, 2000.
4. M. A. Eisenberger, B. A. Blumenstein, E. D. Crawford et al., "Bilateral orchiectomy with or without flutamide for metastatic prostate cancer," The New England Journal of Medicine, vol. 339, no. 15, pp. 1036-1042, 1998.
5. N. Salazar, M. Castellan, S. S. Shirodkar, and B. L. Lokeshwar, "Chemokines and chemokine receptors as promoters of prostate cancer growth and progression," Critical Reviews in Eukaryotic Gene Expression, vol. 23, no. 1, pp. 77-91, 2013.
6. A. Amedei, D. Prisco, and M. M. D'Elios, "The use of cytokines and chemokines in the cancer immunotherapy," Recent Patents on Anti-Cancer Drug Discovery, vol. 8, no. 2, pp. 126-142, 2013.
7. M. L. Gavala, E. A. B. Kelly, S. Esnault et al., "Segmental allergen challenge enhances chitinase activity and levels of CCL18 in mild atopic asthma," Clinical and Experimental Allergy, vol. 43, no. 2, pp. 187-197, 2013.
8. V. Kodelja, C. Müller, O. Politz, N. Hakij, C. E. Orfanos, and S. Goerdt, "Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1α with a Th2-associated expression pattern," Journal of Immunology, vol. 160, no. 3, pp. 1411-1418, 1998.
9. F. O. Martinez, L. Helming, and S. Gordon, "Alternative activation of macrophages: an immunologic functional perspective," Annual Review of Immunology, vol. 27, pp. 451-483, 2009.
10. J. Chen, Y. Yao, C. Gong et al., "CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3," Cancer Cell, vol. 19, no. 4, pp. 541-555, 2011.
11. J. Wu, X. Liu, and Y. Wang, "Predictive value of preoperative serum CCL2, CCL18, and VEGF for the patients with gastric cancer," BMC Clinical Pathology, vol. 13, no. 1, article 15, 2013.
12. Q. Wang, D. Li, W. Zhang, B. Tang, Q. Q. Li, and L. Li, "Evaluation of proteomics-identified CCL18 and CXCL1 as circulating tumor markers for differential diagnosis between ovarian carcinomas and benign pelvic masses," International Journal of Biological Markers, vol. 26, no. 4, pp. 262-273, 2011.
13. V. Urquidi, J. Kim, M. Chang, Y. Dai, C. J. Rosser, and S. Goodison, "CCL18 in a multiplex urine-based assay for the detection of bladder cancer," PLoS ONE, vol. 7, no. 5, Article ID e37797, 2012.
14. D. Li, E. J. Duell, K. Yu et al., "Pathway analysis of genome-wide association study data highlights pancreatic development genes as susceptibility factors for pancreatic cancer," Carcinogenesis, vol. 33, no. 7, pp. 1384-1390, 2012.
15. H. O. Kim, S. I. Cho, B. Y. Chung, H. K. Ahn, C. W. Park, and C. H. Lee, "Expression of CCL1 and CCL18 in atopic dermatitis and psoriasis," Clinical and Experimental Dermatology, vol. 37, no. 5, pp. 521-526, 2012.
16. M. J. Pittet, "Behavior of immune players in the tumormicroenvironment," Current Opinion in Oncology, vol. 21, no. 1, pp. 53-59, 2009.
17. A. Mantovani, S. Sozzani, M. Locati, P. Allavena, and A. Sica, "Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes," Trends in Immunology, vol. 23, no. 11, pp. 549-555, 2002.
18. J. W. Pollard, "Tumour-educated macrophages promote tumour progression and metastasis," Nature Reviews Cancer, vol. 4, no. 1, pp. 71-78, 2004.
19. H. Qin, A. T. Holdbrooks, Y. Liu, S. L. Reynolds, L. L. Yanagisawa, and E. N. Benveniste, "SOCS3 deficiency promotes M1 macrophage polarization and inflammation," Journal of Immunology, vol. 189, no. 7, pp. 3439-3448, 2012.
20. G. Solinas, G. Germano, A. Mantovani, and P. Allavena, "Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation," Journal of Leukocyte Biology, vol. 86, no. 5, pp. 1065-1073, 2009.
21. R. Yuan, Y. Chen, X. He et al., "CCL18 as an independent favorable prognostic biomarker in patients with colorectal cancer," Journal of Surgical Research, vol. 183, no. 1, pp. 163-169, 2013.
22. T. Plönes, A. Krohn, M. Burger et al., "Serum level of CC-chemokine ligand 18 is increased in patients with non-small-cell lung cancer and correlates with survival time in adenocarcinomas," PLoS ONE, vol. 7, no. 7, Article ID e41746, 2012.
23. S. Shimura, G. Yang, S. Ebara, T. M. Wheeler, A. Frolov, and T. C. Thompson, "Reduced infiltration of tumor-associated macrophages in human prostate cancer: association with cancer progression," Cancer Research, vol. 60, no. 20, pp. 5857-5861, 2000.